Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
Sharpeyenj's Profile
Displaying 1-13 of 13 result(s).
GTGP Global Technologies
07/29/2013 9:19:09 AM
Uh, no. I'll leave it there till so
GTGP Global Technologies
07/23/2013 11:09:35 AM
If anyone is interested I have abou
GTGP Global Technologies
03/25/2013 7:06:13 AM
Love how the Ihub contractors are c
GTGP Global Technologies
03/19/2013 9:42:13 AM
Excellent post, worth another read.
GTGP Global Technologies
03/19/2013 9:40:51 AM
Hey 236T568, guess what, the only P
GTGP Global Technologies
03/11/2013 6:15:54 PM
Hiring ad for J3! http://www.nbcmon
GTGP Global Technologies
03/11/2013 3:28:30 PM
Looks like the poor Ihub bashing co
GTGP Global Technologies
03/11/2013 9:26:19 AM
NEWS! J3 CONFIRMED! http://www.mark
GTGP Global Technologies
03/01/2013 5:36:53 PM
Oh yea, big time. All you have to d
GTGP Global Technologies
03/01/2013 11:27:50 AM
This is what is there now, anyone w
GTGP Global Technologies
03/01/2013 11:21:26 AM
This is what used to be at the loca
GTGP Global Technologies
03/01/2013 9:01:10 AM
Exactly what I was gonna do this mo
GTGP Global Technologies
03/01/2013 8:33:47 AM
Holy crap, they are beyond criminal

Recent Articles

  • Investment Insights on Dowlais Group plc's Recent Activities
  • Dramatic Surge in Sales for Zinzino Group Report Q3 Results
  • Navigating Challenges in Sweden's Manufacturing Landscape
  • Dupoin Enhances User Experience and Global Trading Expansion
  • German Enterprises Thrive in India's Expanding GCC Landscape
  • Exploring Germany's Rapid Growth in Indian Offshore Centers
  • Experience Jackbit Casino's Thriving Crypto Gaming World
  • Exploring the Expansion of Data Diode Solutions Market Growth
  • UAB Kvartalas Secures Strong Demand in Fourth Bond Tranche
  • OSB Group PLC Executes Share Buyback Program Successfully
  • Diversified Energy Company: Progress Report on Share Buyback
  • Marc Le Bozec Steps In as Interim CEO for OSE Immunotherapeutics
  • Caledonia Mining's Strategic Share Options Exercise Explained
  • Octopus Apollo VCT: Understanding Its Recent Financial Standing
  • Exploring NB Private Equity Partners' Recent Share Buyback
  • Unlocking the Future of Gaming: Jackbit Crypto Casino's Rakeback
  • Is the Market on the Verge of Another Historic Boom?
  • Actelis Networks Sees Major Stock Surge with New Telecom Deal
  • Bitget's Gracy Chen Champions UNICEF's Global Game Jam
  • AB Volvo Announces Upcoming Press Conference Details
  • Bekaert Advances Share Buyback and Reports Liquidity Updates
  • Dilafor Secures US Patent for Tafoxiparin Development
  • Fingerprint Cards AB's Strategic New Partnership with PixArt
  • AI Infrastructure Investments Soar Amid Growing Market Demands
  • Exciting Insights on M&A Activity in AI Sector Right Now
  • XCel Brands Inc. Experiences Remarkable 66% Surge Post-Trading
  • Tesla's Innovative Patent May Enhance Cybertruck Design
  • Investigation into Danaher Corporation's Leadership Conduct
  • AS Tallink Grupp's Performance Insights for Q3 2025
  • AS Tallink Grupp Reports Passenger Statistics and Trends
  • AKVA Group ASA Secures New Multi-Million RAS Contract
  • Foresight Group Engages in Share Buyback Initiative
  • Join HMS Networks for Insights in Q3 Conference Call
  • Dogecoin's Promising Ascent: Analyst Insights and Market Trends
  • Elon Musk and Tesla: Navigating Criticism Amid Pay Controversy
  • Isomeric Industries Inc. Expands Through Strategic Acquisition
  • Innovative Collaboration Targets HER3 in Cancer Diagnostics
  • Nord Anglia Education's Juilliard Partnership: A Decade of Arts
  • Omio Launches Services in Brazil, Enhancing Travel Options
  • Jeff Bezos Celebrates Blue Origin's Latest Milestone Achievements
  • Exploring Rigetti Computing's Surge: What Investors Should Know
  • Sampo plc Reveals New Share Buyback Details and Impact
  • Join Ferrari's Upcoming Capital Markets Day Online Event
  • Clariant Responds to Competition Law Allegations Asserted by BP and Exxon
  • Leadership Transition at Roche: A New Chapter Begins
  • AGAMREE® Gains Health Canada Approval for DMD Treatment
  • Roche's Tecentriq and Lurbinectedin Reign in Lung Cancer Care
  • Korean Green Solutions Headline International Environmental Fair
  • Innovative Solutions for Southern Europe's Energy Landscape
  • Discover the Culinary Excellence of Vancouver's 2025 Michelin Star Restaurants
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site